Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-30

FDA Approved: SCOPOLAMINE TRANSDERMAL SYSTEM — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved Scopolamine Transdermal System from Padagis Israel Pharmaceuticals Ltd under an original application (ANDA 078830) for the prevention of nausea and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SCOPOLAMINE TRANSDERMAL SYSTEM (scopolamine transdermal system)

Snippet

ORIG AP for SCOPOLAMINE TRANSDERMAL SYSTEM (SCOPOLAMINE TRANSDERMAL SYSTEM)